Webinar: Wisdom from the Front Lines of Successful NDA Submission Programming

MMS is proud to present our latest webinar – Wisdom from the Front Lines of Successful NDA Submission Programming: Utilizing the Biometrics Operational Data Model.
In this free, on-demand webinar you will discover:
- The Biometrics Operational Data Model and explain how submission work can be streamlined across programmers and statisticians
- Validation needs within a submission
- The importance of reviewer’s guides and when they should be built
- Why the NDA submission should be considered during early phases
- Trial domains and how they relate to SDTM, ADaM, and TLFs
- Items that are easy to overlooked during submission planning
Panelists include:
- Jim Bademian, Global Head of Statistical Programming, MMS, North Carolina
- Susheel Arkala, Principal Clinical Programmer and Associate Manager of Programming, MMS, Oregon
- Chris Hurley, Senior Manager of Global Data Operations, Standards and Systems, MMS, Michigan

Run time: 40:47
Suggested For You

perspectives
February 13th, 2025
Helping European Drug Development Companies Succeed in the US Market

perspectives
November 12th, 2024
REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

perspectives
September 30th, 2024
The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives
September 11th, 2024
From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives
July 30th, 2024
The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives
July 23rd, 2024
PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives
July 16th, 2024
Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives
July 9th, 2024
Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives
July 2nd, 2024
Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives
June 21st, 2024
Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives
June 14th, 2024
A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives
June 6th, 2024
Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection